Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integer HoldingsITGR +0.97%83 Buyback Yield % is 1.53 as of Jul. 23, 2026. GuruFocus rates ITGR with a GF Score™ of 83/100 and a GF Value™ of $117.21 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 348 Medical Devices & Instruments companies, Integer Holdings ranks better than 84.2% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Integer Holdings's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ITGR vs HAE, ESTA, IRTC: Buyback Yield % Comparison
For the Medical Devices subindustry, Integer Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integer Holdings Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Integer Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integer Holdings (ITGR) has a Buyback Yield % of 1.53 as of Jul. 23, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Integer Holdings and its competitors. According to the industry distribution chart, Integer Holdings ranks #55 out of 348 companies in the Medical Devices & Instruments industry, placing it in the top 15.8%.
Is Integer Holdings' Buyback Yield % too high?
Integer Holdings' current Buyback Yield % is 1.53. Based on the distribution chart, Integer Holdings ranks #55 out of 348 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Integer Holdings has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integer Holdings' Buyback Yield % compare to HAE and ESTA?
According to the Medical Devices & Instruments industry distribution chart, Integer Holdings ranks #55 out of 348 companies for Buyback Yield %. This places Integer Holdings in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Integer Holdings and its competitors. Integer Holdings's current Buyback Yield % is 1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integer Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integer Holdings (ITGR) is currently considered Modestly Undervalued. The stock's GF Value™ is $117.21, compared to a current price of $97.50 — trading 16.8% below its estimated fair value. The current Buyback Yield % is 1.53. Integer Holdings' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Integer Holdings (ITGR), the current Buyback Yield % is 1.53 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integer Holdings (ITGR) Overvalued in 2026?
Based on GuruFocus' analysis, Integer Holdings stock appears to be undervalued.
The current stock price of $97.50 is trading 16.8% below its estimated GF Value™ of $117.21.
GuruFocus considers Integer Holdings to be Modestly Undervalued.
Key valuation signals for ITGR:
Buyback Yield %: 1.53
GF Value™: $117.21 vs. price of $97.50 (16.8% below fair value)
No single metric tells the full story. See the ITGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
83GF Score
Get the complete analysis for ITGR
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ITGR has been successfully added to your 
